ROYAL BANK OF CANADA - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$81,000
+252.2%
5,322
+341.7%
0.00%
Q1 2024$23,000
-77.0%
1,205
-77.0%
0.00%
Q4 2023$100,0005,229
+28950.0%
0.00%
Q3 2023$0180.0%0.00%
Q2 2023$0
-100.0%
18
-99.4%
0.00%
Q1 2023$54,000
-86.7%
2,987
-84.7%
0.00%
Q4 2022$405,000
+0.2%
19,559
+26.4%
0.00%
Q3 2022$404,000
+3266.7%
15,479
+2959.1%
0.00%
Q2 2022$12,000
-86.4%
506
-81.7%
0.00%
Q1 2022$88,000
-71.1%
2,772
-63.1%
0.00%
Q4 2021$305,000
+258.8%
7,515
+142.3%
0.00%
Q2 2021$85,000
+214.8%
3,102
+217.2%
0.00%
Q1 2021$27,000
+2600.0%
978
+1239.7%
0.00%
Q3 2020$1,000
-66.7%
73
-18.0%
0.00%
Q2 2020$3,000
+50.0%
89
-45.7%
0.00%
Q1 2020$2,000
-93.9%
164
-95.1%
0.00%
Q4 2019$33,000
+43.5%
3,322
+33.5%
0.00%
Q3 2019$23,000
+76.9%
2,489
+55.6%
0.00%
Q2 2019$13,000
+8.3%
1,600
+60.0%
0.00%
Q1 2019$12,000
+9.1%
1,0000.0%0.00%
Q4 2018$11,000
-42.1%
1,000
-26.6%
0.00%
Q3 2018$19,0001,362
+6710.0%
0.00%
Q2 2018$0200.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders